Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury

This publication has 22 references indexed in Scilit:

• Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
  Circulation, 1989
• Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology.
  Circulation, 1989
• Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
  Circulation, 1987
• Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
  Circulation Research, 1986
• Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes
  Journal of the American College of Cardiology, 1986
• Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.
  Circulation, 1986
• Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms
  The American Journal of Cardiology, 1984
• The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
  Circulation Research, 1984
• Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
  Circulation, 1984
• Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease
  New England Journal of Medicine, 1981